Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-20-000009

Sr. VP & Chief Medical Officer gave up 1,091 shares (to pay taxes)

  • Sr. VP & Chief Medical Officer acquired 3,412 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Adda Nathalie · Sr. VP & Chief Medical Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-12 Grant or award : show line 1 in the form +487 13,800 D
2020-02-12 Grant or award : show line 2 in the form +2,925 16,725 D
2020-02-12 Shares withheld for taxes : show line 3 in the form −1,091 $52.76 $57,561 15,634 D
Loading xslF345X03/edgar.xml…